Prospective Analysis of Confocal Laser Endomicroscopy for Assessment of the Resection Bed for Bladder Tumor
2024

Confocal Laser Endomicroscopy for Bladder Tumor Assessment

Sample size: 40 publication Evidence: low

Author Information

Author(s): de Ruiter Ben-Max, Freund Jan E., Savci-Heijink C., van Hattum Jons W., Remmelink Marinka J., de Reijke Theo M., Baard Joyce, Kamphuis Guido M., de Bruin D. Martijn, Oddens Jorg R.

Primary Institution: Amsterdam UMC, Amsterdam, The Netherlands

Hypothesis

Can confocal laser endomicroscopy accurately assess the resection bed for bladder tumors?

Conclusion

Confocal laser endomicroscopy is not a reliable tool for detecting residual tumor or detrusor muscle in the resection bed after bladder tumor surgery.

Supporting Evidence

  • Confocal laser endomicroscopy was able to predict residual tumor in only 50% of cases identified on histopathology.
  • The quality of CLE imaging was low in 18% of cases.
  • Histopathology revealed residual tumor in 23% of patients at 3-month follow-up.

Takeaway

The study looked at a special imaging technique to check for leftover cancer in the bladder after surgery, but it wasn't very good at finding it.

Methodology

The study included 40 participants undergoing transurethral resection of bladder tumors, using confocal laser endomicroscopy to assess the resection bed, with histopathology as the reference test.

Potential Biases

Potential sampling bias in resection bed biopsies.

Limitations

High exclusion rate and low prevalence of residual tumors in biopsies.

Participant Demographics

{"median_age":72,"male_percentage":73,"tumor_size_less_than_3cm_percentage":86,"tumor_stage":{"pTa":59,"pT1":14,"pT2":14,"benign":14}}

Statistical Information

Confidence Interval

{"residual_tumor":"95% CI 0.07–0.93","detrusor_muscle":"95% CI 0.39–0.91"}

Digital Object Identifier (DOI)

10.1016/j.euros.2024.11.007

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication